• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Exits

Equistone sells Uetikon to Ardian's Novacap

  • Kenny Wastell
  • Kenny Wastell
  • 11 May 2015
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Equistone Partners Europe has sold its majority stake in German pharmaceuticals business CU Chemie Uetikon to Ardian portfolio company Novacap.

Under Equistone's ownership, Uetikon has developed its management team. The company intends to expand into new markets under the backing of Novacap.

The deal forms part of Novacap's buy-and-build growth strategy, and will bring new capabilities in active pharmaceutical ingredients and custom synthesis of fine chemicals.

CU Chemie Uetikon

  • DEAL:

    Trade sale

  • LOCATION:

    Lahr

  • SECTOR:

    Pharmaceuticals

  • FOUNDED:

    1970

  • TURNOVER:

    €40m

  • STAFF:

    135

  • VENDOR:

    Equistone Partners Europe

The business received acquisition financing from Ardian in November 2011 for the purchase of French chemical group Rhodia's salicylic and acetaminophen businesses. Novacap also acquired a 51% stake in Taixing Yangzi Pharm Chemical, a Chinese producer of para-aminophenol, the main raw material used for the production of paracetamol.

In January 2011, Ardian (then Axa Private Equity) originally acquired a 96% stake in Novacap in a €240m deal from Bain Capital.

The business completed a €310m refinancing on the high-yield bond market in May 2014, comprising €310m of senior secured floating rate notes, to mature in 2019.

Previous funding
Equistone, (then Barclays Private Equity) wholly acquired Uetikon in October 2011 via a management buyout.

Company
Founded in 1970, Uetikon manufactures fine chemicals and active pharmaceutical ingredients. Based in Lahr, Germany, the firm develops custom synthesis of multilevel intermediaries and active pharmaceutical ingredients.

The business generated a turnover of €40m in 2014, up from €17m at the time Equistone first invested. It has also expanded its headcount from 110 to 135 over the course of the GP's investment.

People
Philippe Stüdi is Equistone's managing director for Switzerland. Stüdi led the deal for the vendor alongside David Zahnd and Peter Hammermann. Thomas Seeler is CEO of Uetikon.

Advisers
Vendor – Lazard (M&A); P+P Pöllath & Partners (Legal); KPMG (Corporate finance, Tax); Novumed (Commercial due diligence); Ecosens (Environmental due diligence).
Acquirer – Ashurst (Legal); PwC (Corporate finance, Tax); Advancy (Commercial due diligence); Latham & Watkins (Operational due diligence); URS (Environmental due diligence).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Exits
  • DACH
  • France
  • France
  • Germany
  • Equistone Partners Europe
  • Ardian (formerly Axa PE)
  • Unq2015June

More on Exits

Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
Lender taking the keys from a sponsor
Ares Management handed keys to two-thirds of UK sponsor’s portfolio

Lender provided GBP 500m for three of the GP's deals between 2016 and 2019, Debtwire reported

  • Financing
  • 30 August 2023
Luggage and airport services
Actera Group explores strategic options for Celebi Ground Handling

Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal

  • Exits
  • 30 August 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013